Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
RSNA 2025
Contact
  • Home
  • /
  • Resources
  • /
  • Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

  • Category: Published research
  • Product: NeuroQuant MS
  • Disease: Multiple sclerosis

This study compares clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. 2012.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • < 1 mins

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

,

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 2 mins

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 3 mins

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

,

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • 3 mins

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • < 1 mins

11/17/2025

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Discover how Imaging Healthcare Specialists integrated OnQ™ Prostate to enhance lesion visibility, boost diagnostic confidence, and improve communication.

View our insights
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top